Clinical trial

A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

NCT00780975

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-02-01

PhasePHASE2

Study timeline

Study start (unknown)2005-02-01Date precision: month

Registry last updated2020-11-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Aplidin (plitidepsin)DRUG

Sponsors & collaborators

PharmaMarlead sponsor

Mapped research locations

SeattleWashington, United States1 Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00780975 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.